Science Explorer Interactive view Map
Company · Wilmington · United States

Sun Pharma (United States)

sunpharma.com/usaROR OpenAlex
Research works
35
▲ 304% vs 2013–17
Citations
329
9.5 per fractional work
Top-10% rate
8.6%
record average 16.5%
Open access
56%
world 28%

Not ranked overall: Sun Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.78× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 17.87× its world share, 2 worksImmunology and Micro…Neuroscience: 1.24× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.36× its world share, 0 worksPharmacology, Toxico…Engineering: 0.12× its world share, 0 worksEngineeringMaterials Science: 0.17× its world share, 0 worksMaterials ScienceHealth Professions: 0.27× its world share, 0 worksHealth ProfessionsMedicine: 3.48× its world share, 8 worksMedicineEconomics, Econometrics and Finance: 2.07× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 17.9×. Every wedge is a field page.

Who are the top researchers at Sun Pharma (United States)?

Ranked on the composite score, Alan M. Mendelsohn lead among researchers whose main affiliation is Sun Pharma (United States).

  1. 1 Alan M. Mendelsohn United States · #711,055 worldwide 36 citations · 18 works
All ranked researchers at Sun Pharma (United States)

Which keywords describe research at Sun Pharma (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammatory Cytokines, Epidemiology, Immune System, IL-17, TH17 Cells, Quality of Life, Inflammation and Dry Eye Disease.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Inflammatory Cytokines6▲ 265×2 topics
  2. Epidemiology6▲ 4.4×20 topics
  3. Immune System4▲ 40×2 topics
  4. IL-174▲ 505×1 topic
  5. TH17 Cells4▲ 505×1 topic
  6. Inflammation3▲ 3.7×13 topics
  7. Quality of Life3▲ 5.7×6 topics
  8. Dry Eye Disease2▲ 173×1 topic
  9. Ocular Surface2▲ 173×1 topic
  10. Cancer2▲ 4.1×7 topics
  11. Immune Dysregulation2▲ 65×2 topics
  12. Filaggrin2▲ 116×1 topic
  13. Skin Microbiome2▲ 116×1 topic
  14. Photodynamic Therapy2▲ 27×3 topics
  15. Ankylosing Spondylitis1▲ 179×1 topic
  16. Clinical Trials1▲ 6.6×5 topics
  17. Nanoparticles1▲ 3.1×5 topics
  18. Spondyloarthritis1▲ 179×1 topic
  19. Treatment1▲ 3.0×6 topics
  20. Antibiotic Resistance1▲ 9.6×2 topics
  21. Cost-effectiveness Analysis1▲ 48×1 topic
  22. Diagnosis1▲ 3.8×6 topics
  23. Health Utility Measures1▲ 48×1 topic
  24. Autoantibodies1▲ 13×5 topics
  25. Antioxidant1▲ 4.4×3 topics
  26. Antiviral1▲ 32×3 topics
  27. Drug Delivery1▲ 6.0×3 topics

Which research topics does Sun Pharma (United States) publish most on?

By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, Acne and Rosacea Treatments and Effects, Dermatology and Skin Diseases and Chronic Myeloid Leukemia Treatments.

Psoriasis: Treatment and…2Psoriasis: Treatment and Pathogenesis: 2 fractional worksAcne and Rosacea Treatme…1Acne and Rosacea Treatments and Effects: 1 fractional worksDermatology and Skin Dis…1Dermatology and Skin Diseases: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksSpondyloarthritis Studie…0Spondyloarthritis Studies and Treatments: 0 fractional worksOcular Surface and Contact Lens: 0 fractional worksAutoimmune Bullous Skin Diseases: 0 fractional worksCytokine Signaling Pathways and Interactions: 0 fractional worksHedgehog Signaling Pathway Studies: 0 fractional works
ImmunologyDermatologyHematologyEconomics and Econometrics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 2 works
  2. 2 Acne and Rosacea Treatments and Effects Dermatology 1 works
  3. 3 Dermatology and Skin Diseases Dermatology 1 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 1 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  6. 6 Spondyloarthritis Studies and Treatments Rheumatology 0 works
  7. 7 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
  8. 8 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 0 works
  9. 9 Cytokine Signaling Pathways and Interactions Oncology 0 works
  10. 10 Hedgehog Signaling Pathway Studies Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.9%not open44.1%

World: 28% of research is openly available.

with international co-authors39.1%domestic only60.9%

World: 19% is written across borders.

How has Sun Pharma (United States)'s research output changed?

Output in 2018–2022 was 304% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Wilmington

All research institutions in Wilmington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.